ISPOR - A Cost-Utility Analysis of Prosigna®, A 50 Gene Test for Predicting Breast Cancer Recurrence, in the Australian Setting

Full Text

A Cost-Utility Analysis of Prosigna®, A 50 Gene Test for Predicting Breast Cancer Recurrence, in the Australian Setting

Abstract

Authors

A Vogan CM Schubert

Back to Volume 21, Supplemental S2

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now